2014
DOI: 10.1371/journal.pone.0104396
|View full text |Cite
|
Sign up to set email alerts
|

Whole-Genome Sequencing of Individuals from a Founder Population Identifies Candidate Genes for Asthma

Abstract: Asthma is a complex genetic disease caused by a combination of genetic and environmental risk factors. We sought to test classes of genetic variants largely missed by genome-wide association studies (GWAS), including copy number variants (CNVs) and low-frequency variants, by performing whole-genome sequencing (WGS) on 16 individuals from asthma-enriched and asthma-depleted families. The samples were obtained from an extended 13-generation Hutterite pedigree with reduced genetic heterogeneity due to a small fou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(29 citation statements)
references
References 83 publications
1
28
0
Order By: Relevance
“…Human genetic studies have associated variants in NDFIP1 with asthma52 and other inflammatory diseases (that is, rheumatoid arthritis53 and inflammatory bowel disease54). More recently, in a whole-genome sequencing study on individuals from a Hutterite population, a 6 kbp deletion in an intron in NEDD4L has been associated with increased risk of asthma23. Our experimental findings here, raise the possibility that such genetic alterations perturb the ability of Nedd4-2 to negatively regulate mast cell signalling, as well as that of other cell populations expressing this ligase and adaptor50, resulting in sustained inflammatory responses and a contribution to the sequelae of allergic disease in affected individuals.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Human genetic studies have associated variants in NDFIP1 with asthma52 and other inflammatory diseases (that is, rheumatoid arthritis53 and inflammatory bowel disease54). More recently, in a whole-genome sequencing study on individuals from a Hutterite population, a 6 kbp deletion in an intron in NEDD4L has been associated with increased risk of asthma23. Our experimental findings here, raise the possibility that such genetic alterations perturb the ability of Nedd4-2 to negatively regulate mast cell signalling, as well as that of other cell populations expressing this ligase and adaptor50, resulting in sustained inflammatory responses and a contribution to the sequelae of allergic disease in affected individuals.…”
Section: Discussionmentioning
confidence: 99%
“…To date, Nedd4-2 is best known for its ability to regulate stability and activity of ion channels and transporters, particularly in epithelial cells22, but little is known about the role of this ubiquitin ligase in allergic inflammation. Recently, genetic studies from asthma-enriched families have identified a variant in NEDD4L associated with increased risk of the disease23. We have found that mast cells express Nedd4-2 and importantly, loss of Nedd4-2 in foetal liver-derived mast cells (FLMCs) or bone marrow-derived cultured mast cells (BMCMCs) not only results in heightened and sustained pro-inflammatory mediator release by mast cells in vitro , but also in prolonged IgE-mediated passive cutaneous anaphylaxis reactions in three different types of mast cell-deficient mice engrafted with Nedd4-2 −/− mast cells.…”
mentioning
confidence: 99%
“…They were unable to show that the asthmatic members have significantly higher burden of rare variants. Recently, Campbell et al 60 conducted a whole genome sequencing (WGS) on 16 individuals (8 asthmatic) from a Hutterite population in order to find novel asthma genetic variants that have not been uncovered in previous GWASs. However, none of their discovered variants met genome-wide significance threshold, specifically mutations within gene NEDD4L, which contributes to the ubiquitination of specific proteins for lysosomal degradation.…”
Section: Resultsmentioning
confidence: 99%
“…9 candidate asthma genes in 965 subjects 17 ) or for discovery in limited numbers of individuals (e.g. whole genome sequencing in 16 subjects with well-characterized asthma 18 ).…”
Section: Genomementioning
confidence: 99%